https://www.selleckchem.com/pe....ptide/lypressin-acet
Purpose To explore the therapeutic effects and prognosis of osimertinib combined with docetaxel for non-small cell lung cancer (NSCLC). Methods A total of 94 patients with NSCLC diagnosed in the oncology department of our hospital were selected and randomly divided into two groups of 47 patients each. Patients in the control group took osimertinib tablets, while patients in the drug combination group were given intravenous docetaxel in addition to the oral administration of osimertinib. The therapeutic effects, inflammatory fac
Like
Comment
Share
